Skip to content
Advertisement

This photo provided by Janssen Biotech, Inc. shows the drug Tremfya. On Thursday, July 13, 2017, the Food and Drug Administration approved the new drug Tremfya, from Johnson & Johnson, for people with moderate to severe plaque psoriasis. (Janssen Biotech, Inc. via AP)

This photo provided by Janssen Biotech, Inc. shows the drug Tremfya. On Thursday, July 13, 2017, the Food and Drug Administration approved the new drug Tremfya, from Johnson & Johnson, for people with moderate to severe plaque psoriasis. (Janssen Biotech, Inc. via AP)

Featured Photo Galleries